Skip to content
Barrett Esophagus and Esophageal Cancer

GI

Barrett Esophagus and Esophageal Cancer

Goblet cells reveal Barrett, keratin points to squamous cancer, and dysplasia determines when surveillance becomes treatment.

Primary diagnostic image
Goblet-cell intestinal metaplasia replaces squamous mucosa. That histologic switch defines Barrett esophagus.Mikael Häggström, M.D. / Wikimedia Commons (CC0). Source CC0
  • Recognize Barrett esophagus histologically and anatomically
  • Distinguish esophageal adenocarcinoma from squamous-cell carcinoma
  • Use dysphagia progression and risk factors to recognize malignancy

Key distinctions

Separate the closest diagnoses

The figure compares the nearest alternatives and highlights the finding that separates them.

Quick check

Endoscopy after years of reflux shows salmon-colored distal esophageal mucosa above the gastric folds; biopsy finds columnar epithelium with intestinal goblet cells.

What change in the esophageal lining is present?

Progressive solids-then-liquids dysphagia is mechanical until proven otherwise

A fixed narrowing excludes solids before it excludes liquids.

Esophageal cancer may remain silent until luminal narrowing finally interferes with swallowing.

Mechanical obstruction typically impairs solids first and liquids later; many primary motility disorders affect both from the start.

In an older adult, new dysphagia with rapid weight loss, iron-deficiency anemia, odynophagia, or bleeding warrants prompt endoscopic evaluation for malignancy.

Which dysphagia pattern most strongly suggests an enlarging esophageal mass?

Choose the first item.

Progressive loss of lumen caliber is felt by solids before liquids.

Adenocarcinoma versus squamous-cell carcinoma

Tumor location and histology preserve the history of the carcinogenic exposure.

Adenocarcinoma usually arises distally or near the gastroesophageal junction through a Barrett pathway associated with chronic reflux and obesity.

Squamous-cell carcinoma more often occupies the middle or upper esophagus and tracks with tobacco, alcohol, achalasia, caustic injury, prior radiation, very hot beverages, and selected dietary or environmental exposures.

Either tumor may present late with dysphagia, weight loss, anemia, bleeding, or pain; biopsy and staging, not symptoms alone, establish the disease.

Switch between the major tumor types.

Adenocarcinoma

Distal esophagus; chronic GERD, Barrett esophagus, central obesity, male sex, and tobacco exposure.

Distal reflux favors glands; proximal toxin or stasis exposure favors malignant squamous cells.

Risk rises along the Barrett spectrum

Most metaplastic segments never become cancer, but confirmed dysplasia changes the plan.

Nondysplastic Barrett has a low annual absolute cancer risk, so care centers on reflux control and guideline-based surveillance rather than automatic ablation.

Confirmed low-grade dysplasia raises progression risk; high-grade dysplasia creates a more immediate threat that usually prompts endoscopic eradication or resection.

Classify each state by relative progression risk.

Normal distal squamous mucosa

Lower progression risk

Metaplasia creates the vulnerable field, while dysplasia signals neoplastic progression.

The Z line is the landmark

Barrett crosses a visible junction, but color means little unless the gastric folds are located.

The Z line normally approximates the gastroesophageal junction, which endoscopy identifies by the proximal gastric folds rather than color alone.

Barrett mucosa forms tongues or a circumferential segment of salmon-colored epithelium above the junction and, in standard United States practice, requires biopsy-proven intestinal metaplasia.

Because Barrett-related adenocarcinoma lies near the cardia, staging must separate esophageal disease from gastric-junction disease.

Open each distal-esophageal landmark.

1Squamous esophagus

Pale stratified squamous mucosa normally lines the tubular esophagus.

2Z line

Visible transition between squamous and columnar mucosa.

3Gastroesophageal junction

Defined by the proximal extent of gastric folds and related anatomy.

4Barrett segment

Columnar mucosa extends above the junction and is sampled systematically.

5Gastric cardia

Proximal stomach immediately below the junction; tumors here may overlap junctional classifications.

Reflux can progress through a metaplasia-dysplasia sequence

Reflux-driven adaptation becomes dangerous only after neoplastic atypia appears.

Recurrent reflux injures distal squamous epithelium and selects for columnar intestinal-type repair.

Barrett metaplasia is not cancer, although persistent injury and acquired molecular alterations can lead from low-grade to high-grade dysplasia.

High-grade dysplasia and intramucosal adenocarcinoma require expert pathologic confirmation plus definitive endoscopic or surgical management because progression risk is substantial.

Reveal the progression pathway.

  1. Chronic gastroesophageal reflux

    Acid and nonacid reflux repeatedly injure distal squamous mucosa.

Why esophageal cancer spreads early

A thin wall and longitudinal lymphatic channels let a short lesion travel far.

Without a complete serosal covering, an esophageal tumor can directly invade the adjacent trachea, bronchi, aorta, pericardium, pleura, or recurrent laryngeal nerves.

Longitudinal submucosal lymphatics carry disease to nodes above and below the visible tumor, making lesion length an unreliable guide to stage.

Hoarseness, cough with swallowing, airway symptoms, bone pain, liver lesions, or supraclavicular adenopathy can reveal local invasion or metastasis.

Open the route or clinical consequence.

  1. Submucosal lymphatics

    Permit longitudinal skip spread to cervical, mediastinal, or upper-abdominal nodes.

Decisive finding

Pick the discriminator

Choose the finding that separates the closest competing diagnoses.

What change in the esophageal lining is present?

Stage 1 of 3: Overview

Overview

Barrett Esophagus and Esophageal Cancer

Reflux-driven adaptation becomes dangerous only after neoplastic atypia appears.

Separate the competing diagnoses

Five cases move from reflux-associated tumor recognition through mucosal histology, dysplasia management, endoscopic landmarks, and neoplastic progression.

Cross out mimics and highlight the finding that separates the diagnoses. Shuffle to compare a new case order.

A man with central obesity and long-standing reflux develops dysphagia for solids, followed months later by difficulty with liquids. Endoscopy finds a distal esophageal mass; biopsy shows malignant glands.

Which Barrett-associated complication has developed?

Rapid review

Three questions to check

What change in the esophageal lining is present?

Barrett esophagus. Barrett esophagus is specialized intestinal metaplasia of the distal esophagus with goblet cells replacing normal squamous mucosa.

Which history supplies the precursor lesion?

Chronic reflux and central obesity support Barrett metaplasia in the distal esophagus.

What does gland formation establish?

A malignant gland-forming tumor in this location is esophageal adenocarcinoma.

Medically reviewed

Fatima Ali, DO

Fatima Ali, DO

PGY-1 Resident Physician in Psychiatry

University Hospitals, Columbia

DO from Kansas City University

Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.

Languages: English, Urdu

Primary reviewerFull physician profile

Medically reviewed

Sources

  1. Barrett Esophagus2026
  2. Esophageal Cancer2026
  3. Gastroesophageal Reflux Disease2025
  4. Achalasia2026
  5. Diagnosis and Management of Barrett’s Esophagus: An Updated ACG Guideline2022
  6. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease2021

Bone Wizardry is a study resource for medical students. It is not medical advice.